Press Release: GigaGen : ProteoNic announces broadening of GigaGen's rights to 2G UNic Technology
LEIDEN, Netherlands, Nov. 1, 2022 /PRNewswire/ -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of...
Read full article »
GigaGen is a biotechnology company that develops and commercializes single-cell technology-based antibody drugs to treat infectious diseases.
Read more